A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

類似資料

• A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
  著者:: Chen, Y, 等
  出版事項: (2006)
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
  著者:: Jobanputra, P, 等
  出版事項: (2002)
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
  著者:: Jobanputra, P, 等
  出版事項: (2002)
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
  著者:: P. Jobanputra, 等
  出版事項: (2002-01-01)
• Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
  著者:: K Malottki, 等
  出版事項: (2011-03-01)